- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Ted Okon Discusses How COA Members Responded to Challenges of COVID-19
Ted Okon, MBA, executive director, Community Oncology Alliance (COA), speaks on the most significant challenges members encountered in the past year managing the COVID-19 pandemic ahead of the 2021 Community Oncology Conference.
Ted Okon, MBA, is the executive director of the Community Oncology Alliance.
Transcript
A year into the pandemic, what are the biggest challenges for COA members?
Okon: As we are now officially at the 1-year mark of the COVID-19 pandemic, challenges just abound. If you think about it, community oncology practices have had to reinvent themselves literally to keep their facilities and their providers, their staff, COVID-19 free so they can continue to treat patients. Especially as hospitals have been overrun with COVID-19, cancer care has really relied on the backbone of community oncology practices.
So, the biggest challenge has been basically how to reinvent yourself, how to think about the processes, both clinical and operationally, that you do so that you continue to treat patients. And I can tell you that the beauty of it is, is that community oncology practices, independent practices are up, running, healthy; seeing patients like never before; and dealing with the normal challenges of PBMs [pharmacy benefit managers] and everything else like that. I think they've done a remarkable job and put herculean efforts forth in terms of dealing with a pandemic and being able to keep the doors open.
HIVconsvX Vaccine Shows Safety, Immune Response in People on ART
March 10th 2025This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of immune reconstitution.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
